Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Olema Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| | | | | | | | | | | | | | | | |
| | Security Type | | Security Class Title | | Fee Calculation Rule | | Amount Registered(1) | | Proposed Maximum Offering Price Per Unit(2) | | Maximum Aggregate Offering Price | | Fee Rate | | Amount of Registration Fee |
Newly Registered Securities |
| | | | | | | | |
Fees to be Paid | | Equity | | Common Stock, par value $0.0001 per share | | Other | | 13,211,381 | | $11.23 | | $148,363,808.63 | | 0.00014760 | | $21,898.50 |
Fees Previously Paid | | — | | — | | — | | — | | — | | — | | — | | — |
Carry Forward Securities |
Carry Forward Securities | | — | | — | | — | | — | | — | | — | | — | | — |
| | Total Offering Amounts | | 13,211,381 | | — | | $148,363,808.63 | | — | | $21,898.50 |
| | | | | |
| | Total Fees Previously Paid | | — | | — | | — | | — |
| | | | | |
| | Total Fee Offsets | | — | | — | | — | | — |
| | | | | |
| | Net Fee Due | | — | | — | | — | | $21,898.50 |
| |
(1) | This registration statement registers the resale of 13,211,381 outstanding shares of common stock of the Olema Pharmaceuticals, Inc. (the “Registrant”) held by the selling stockholders identified in this registration statement. The shares of common stock may be offered for resale by the selling stockholders pursuant to the prospectus contained herein. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers any additional number of shares of common stock issuable upon stock splits, stock dividends, or other distribution, recapitalization or similar events with respect to the shares of common stock being registered pursuant to this registration statement. |
| |
(2) | Estimated in accordance with Rule 457(c) under the Securities Act, solely for purposes of calculating the registration fee based on $11.23, which is the average of the high and low price per share of the Registrant’s common stock as reported on The Nasdaq Global Select Market on January 29, 2024. |